Amlodipine/benazepril

Amlodipine/benazepril
Combination of
Amlodipine Calcium channel blocker
Benazepril ACE inhibitor
Clinical data
Pregnancy
category
  • US: D (Evidence of risk)
Legal status
Routes of
administration
Oral
Identifiers
ATC code None
PubChem CID 5746247
ChemSpider 4676979 YesY
  (verify)

Amlodipine/benazepril, marketed in the U.S. as Lotrel by Novartis and manufactured as a generic drug by Teva and Sandoz, is an antihypertensive medication which combines a calcium channel blocker (amlodipine besilate) with an angiotensin converting enzyme inhibitor (benazepril).[1] This drug, like similar combinations, is prescribed when either agent alone is not sufficient to bring a person's blood pressure down to target range. As a combination agent, Lotrel shares the adverse reaction profile of both of its individual parts.[2][3]

See also

References

External links


This article is issued from Wikipedia - version of the Tuesday, January 29, 2013. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.